Publications by authors named "Beth D Weatherley"

Claim this Profile
L
Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF study.
Olga Milo-Cotter, John R Teerlink, Marco Metra, G Michael Felker, Piotr Ponikowski, Beth Davison Weatherley

Cardiology· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
Adriaan A Voors, Howard C Dittrich, Barry M Massie, Paul DeLucca, George A Mansoor, Beth D Weatherley

J Am Coll Cardiol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of leukocyte counts on admissions for acute heart failure--presentation and outcome--results from a community based registry.
Olga Milo-Cotter, G Michael Felker, Nir Uriel, Edo Kaluski, Christopher Edwards, Beth Davison Weatherley

Int J Cardiol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled trial of the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness.
Eyal Shemesh, Rachel A Annunziato, Beth D Weatherley, Gad Cotter, John R Feaganes

J Clin Psychiatry· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute heart failure clinical drug development: from planning to proof of activity to phase III.
Gad Cotter, Adriaan A Voors, Beth Davison Weatherley, Peter S Pang, John R Teerlink

Cardiology· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function.
Piotr Ponikowski, Veselin Mitrovic, Christopher M O'Connor, Howard Dittrich, Gad Cotter, Beth D Weatherley

Eur J Heart Fail· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.
Marco Metra, John R Teerlink, G Michael Felker, Barry H Greenberg, Gerasimos Filippatos, Beth Davison Weatherley

Eur J Heart Fail· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.
Barry M Massie, Christopher M O'Connor, Marco Metra, Piotr Ponikowski, John R Teerlink, Beth Davison Weatherley

N Engl J Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.
Marco Metra, John G Cleland, Beth Davison Weatherley, Howard C Dittrich, Michael M Givertz

Eur J Heart Fail· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.
Gad Cotter, Marco Metra, Beth Davison Weatherley, Howard C Dittrich, Barry M Massie

Cardiology· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
Beth Davison Weatherley, Gad Cotter, Howard C Dittrich, Paul DeLucca, George A Mansoor

J Card Fail· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid clinical assessment of patients with acute heart failure: first blood pressure and oxygen saturation--is that all we need?
Olga Milo-Cotter, Gad Cotter, Edo Kaluski, Michele M Rund, G Michael Felker, Beth Davison Weatherley

Cardiology· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?
Beth Davison Weatherley, Olga Milo-Cotter, G Michael Felker, Nir Uriel, Edo Kaluski

Fundam Clin Pharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome.
Guillermo Torre-Amione, Olga Milo-Cotter, Edo Kaluski, Loic Perchenet, Isaac Kobrin, Beth Davison Weatherley

J Card Fail· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.
John R Teerlink, Marco Metra, G Michael Felker, Piotr Ponikowski, Adriaan A Voors, Beth Davison Weatherley

Lancet· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
Gad Cotter, Howard C Dittrich, Beth Davison Weatherley, Daniel M Bloomfield, Christopher M O'Connor

J Card Fail· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia.
Olga Milo-Cotter, Gad Cotter, Beth D Weatherley, Kirkwood F Adams, Edo Kaluski

Eur J Heart Fail· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study.
Keattiyoat Wattanakit, Aaron R Folsom, Daniel A Duprez, Beth D Weatherley, Alan T Hirsch

Atherosclerosis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study.
Keattiyoat Wattanakit, Aaron R Folsom, Elizabeth Selvin, Josef Coresh, Alan T Hirsch, Beth D Weatherley

J Am Soc Nephrol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study, 1987-2001.
Beth D Weatherley, Jeanenne J Nelson, Gerardo Heiss, Lloyd E Chambless, A Richey Sharrett

BMC Cardiovasc Disord· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The reliability of the ankle-brachial index in the Atherosclerosis Risk in Communities (ARIC) study and the NHLBI Family Heart Study (FHS).
Beth D Weatherley, Lloyd E Chambless, Gerardo Heiss, Diane J Catellier, Curtis R Ellison

BMC Cardiovasc Disord· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
Keattiyoat Wattanakit, Aaron R Folsom, Elizabeth Selvin, Beth D Weatherley, James S Pankow

Atherosclerosis· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Have studies of urinary tract infection and preterm delivery used the most appropriate methods?
Marie S O'Neill, Irva Hertz-Picciotto, Lisa M Pastore, Beth D Weatherley

Paediatr Perinat Epidemiol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis